Business

Neurim Pharmaceuticals markets its new drugs through strategic alliances with reputable marketing and distribution partners on whose marketing expertise we rely.

Neurim has so far established marketing and sales agreements with Teva, Takeda, Aspen Pharmacare, DKSH, Pliva, Flynn, Desitin, Italfarmaco, Biocodex and Luye Pharma.
We are actively seeking additional strategic alliances.

Please feel free to contact us:

Eran Schenker, MD
Director, Corporate Business Development
Email: business@neurim.com
Tel: +972 52 6689944

  • Text size: A A A
  • Circadin

  • Recent news

    • Neurim Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of Piromelatine for the Treatment of Insomnia
    • Neurim Pharmaceuticals reports the results of stabilometric study of Circadin® demonstrating maintenance of postural stability
    • Neurim Pharmaceuticals announces positive results from phase I and Ib clinical trials with Neu-P11, a sleep maintenance drug

  • Partners

    Partners